The Onset of Sarcoidosis in Relation to Tattoos: Focus on the Treatment Landscape. A Critical Literature Review and Case Report

This is a preview and has not been published.

The Onset of Sarcoidosis in Relation to Tattoos: Focus on the Treatment Landscape. A Critical Literature Review and Case Report

Authors

  • Giorgio Monteleone Department of Pneumology, Ruhrlandklinik, University Hospital, University of Duisburg-Essen, 45147 Essen, Germany
  • Andrea Salotti Pulmonology Unit, Department of Sciences, Medical Surgical and Health University Hospital of Cattinara, University of Trieste, 34149 Trieste, Italy.
  • Riccardo Ture Pulmonology Unit, Department of Sciences, Medical Surgical and Health University Hospital of Cattinara, University of Trieste, 34149 Trieste, Italy.
  • Giulia Bandini Department of Experimental and Clinical Medicine, Division of Internal Medicine, Azienda Ospedaliera Universitaria Careggi, University of Florence, 50134 Florence, Italy.
  • Michael Hughes Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Science, School of Biological Sciences, The University of Manchester, Manchester M13 9PT, UK. ⁵ Department of Rheumatology, Northern Care Alliance NHS Foundation Trust, The University of Manchester, Manchester M13 9PL, UK. ⁶ NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester M6 8HD, UK.
  • Paola Confalonieri Pulmonology Unit, Department of Sciences, Medical Surgical and Health University Hospital of Cattinara, University of Trieste, 34149 Trieste, Italy.
  • Francesco Salton Pulmonology Unit, Department of Sciences, Medical Surgical and Health University Hospital of Cattinara, University of Trieste, 34149 Trieste, Italy.
  • Marco Confalonieri Pulmonology Unit, Department of Sciences, Medical Surgical and Health University Hospital of Cattinara, University of Trieste, 34149 Trieste, Italy.
  • Barbara Ruaro Pulmonology Unit, Department of Sciences, Medical Surgical and Health University Hospital of Cattinara, University of Trieste, 34149 Trieste, Italy.

Keywords:

Sarcoidosis; Tattoo sarcoidosis; Cutaneous sarcoidosis

Abstract

Sarcoidosis is a complex multisystem granulomatous disease characterized by the formation of non-caseating granulomas in affected tissues, primarily involving the lungs and the lymphatic system. While its precise etiology remains elusive, a combination of genetic predisposition, environmental factors, and immune dysregulation is believed to contribute to disease development. In recent years, an intriguing association has emerged between cutaneous sarcoidosis and tattooing. Several case reports and observational studies have documented instances where sarcoid granulomas develop within tattooed skin, often with concurrent systemic involvement. This review explores the existing literature on the relationship between tattoos and sarcoidosis, examining proposed pathogenic mechanisms, clinical presentations, and implications for diagnosis and management. The evidence suggests that tattoo pigments—particularly those containing metals and organic compounds—may act as foreign bodies, eliciting a localized granulomatous immune response that can potentially trigger or reflect systemic disease. Although causality remains unproven, understanding this association is vital for clinicians managing patients with granulomatous skin lesions and for public health considerations related to tattoo safety. Further research is necessary to clarify the pathophysiological links and to identify individuals at risk, ultimately guiding preventive strategies and tailored therapeutic approaches.

References

1. Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Muller-Quernheim J. Sarcoidosis. Nat Rev Dis Primers. 2019;5(1):45. doi: 10.1038/s41572-019-0096-x

2. Llanos O, Hamzeh N. Sarcoidosis. Med Clin North Am. 2019;103(3):527-534. doi: 10.1016/j.mcna.2018.12.011

3. Ungprasert P, Matteson EL. Neurosarcoidosis. Rheum Dis Clin North Am. 2017;43(4):593-606. doi: 10.1016/j.rdc.2017.06.008

4. Kluger N. Cutaneous and systemic complications associated with tattooing. Presse Med. 2016;45(6 Pt 1):567-576. doi: 10.1016/j.lpm.2016.02.016

5. Kluger N. An update on cutaneous complications of permanent tattooing. Expert Rev Clin Immunol. 2019;15(11):1135-1143. doi: 10.1080/1744666X.2020.1676732

6. Tukenmez Demirci G, Mansur AT, Yildiz S, Gulec AT. Is it a sarcoidal foreign-body granuloma or a cutaneous sarcoidosis on a permanent eyebrow make-up? J Cosmet Laser Ther. 2016;18(1):50-52. doi: 10.3109/14764172.2015.1052516

7. Serup J. Diagnostic tools for doctors' evaluation of tattoo complications. Curr Probl Dermatol. 2017;52:42-57. doi: 10.1159/000450778

8. Faint A, Daveson AJM. Tattoo sarcoidosis presenting as abdominal allodynia. Med J Aust. 2022;217(1):23. doi: 10.5694/mja2.51603

9. Kluger N. Tattoo-associated uveitis with or without systemic sarcoidosis: a comparative review of the literature. J Eur Acad Dermatol Venereol. 2018;32(11):1852-1861. doi: 10.1111/jdv.15070

10. Serup J, Baumler W. Guide to treatment of tattoo complications and tattoo removal. Curr Probl Dermatol. 2017;52:132-138. doi: 10.1159/000452966

11. Redl A, Doberer K, Unterluggauer L, et al. Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial. Lancet Rheumatol. 2024;6(2):e81-e91. doi: 10.1016/S2665-9913(23)00302-8

12. Nawras A, Alsolaiman MM, Mehboob S, Bartholomew C, Maliakkal B. Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature. Dig Dis Sci. 2002;47(7):1627-1631. doi: 10.1023/a:1015843908536

13. Serup J. Medical treatment of tattoo complications. Curr Probl Dermatol. 2017;52:74-81. doi: 10.1159/000450804

14. Serup J. Atlas of illustrative cases of tattoo complications. Curr Probl Dermatol. 2017;52:139-229. doi: 10.1159/000453379

15. Hirani S, Kulkarni S, Flowers AB. Tattoo-associated sarcoidosis. Am J Med. 2020;133(12):1416-1417. doi: 10.1016/j.amjmed.2020.04.027

16. Kushima H, Kinoshita Y, Ishii H, Fujita M. Tattoo-induced systemic sarcoidosis. BMJ Case Rep. 2020;13(8):e237723. doi: 10.1136/bcr-2020-237723

17. Ishimaru N, Ohnishi J, Seto H, Kanzawa Y, Sano N, Kinami S. Therapeutic dilemma of sarcoidosis and treatment-naive hepatitis C manifesting as tattoo reactions. Intern Med. 2021;60(4):645-650. doi: 10.2169/internalmedicine.5606-20

18. Thrasher M, Blaikie H, Thompson A, Demediuk B. Tattoo-associated sarcoidosis with hepatic and ophthalmic involvement. BMJ Case Rep. 2024;17(4):e258946. doi: 10.1136/bcr-2023-258946

19. Paolino A, Galloway J, Birring S, et al. Clinical phenotypes and therapeutic responses in cutaneous-predominant sarcoidosis: 6-year experience in a tertiary referral service. Clin Exp Dermatol. 2021;46(6):1038-1045. doi: 10.1111/ced.14614

20. Dai C, Shih S, Ansari A, Kwak Y, Sami N. Biologic therapy in the treatment of cutaneous sarcoidosis: a literature review. Am J Clin Dermatol. 2019;20(3):409-422. doi: 10.1007/s40257-019-00428-8

21. Albers CC, Metze D, Steinbrink K, Bohm M. Systemic sarcoidosis with cutaneous tattoo involvement following COVID-19 vaccination. Acta Derm Venereol. 2023;103:adv6244. doi: 10.2340/actadv.v103.6244

22. Martin-Callizo C, Marcoval J, Penin RM. Granulomatous reactions to red tattoo pigments: a description of 5 cases. Actas Dermosifiliogr. 2015;106(7):588-590. doi: 10.1016/j.ad.2014.12.010

23. Melani AS, Bigliazzi C, Cimmino FA, Bergantini L, Bargagli E. A comprehensive review of sarcoidosis treatment for pulmonologists. Pulm Ther. 2021;7(2):325-344. doi: 10.1007/s41030-021-00160-x

24. Sheu J, Saavedra AP, Mostaghimi A. Rapid response of tattoo-associated cutaneous sarcoidosis to minocycline: case report and review of the literature. Dermatol Online J. 2014;20(8).

25. Fazzi P. Pharmacotherapeutic management of pulmonary sarcoidosis. Am J Respir Med. 2003;2(4):311-320. doi: 10.1007/BF03256659

26. Nicolosi S, Chernovsky M, Angoni D, Hughes M, Bandini G, McMahan Z, et al. Gastrointestinal manifestations of sarcoidosis: a state-of-the-art, comprehensive review of the literature—practical clinical insights and many unmet needs on diagnosis and treatment. Pharmaceuticals (Basel). 2024;17(9):1106. doi: 10.3390/ph17091106

27. Pozzan R, Salton F, Confalonieri P, Trotta L, Barbieri M, Reccardini N, et al. Autoantibodies in sarcoidosis: innocent bystander or promising biomarker for organ involvement? Sarcoidosis Vasc Diffuse Lung Dis. 2024;41(4):e2024056. doi: 10.36141/svdld.v41i4.16043

28. Mondini L, Barbieri M, Trotta L, Monteleone G, Ruggero L, De Nes A, et al. Exploring sarcoidosis via nailfold capillaroscopy: a window into the disease's microvascular landscape. Sarcoidosis Vasc Diffuse Lung Dis. 2025;42(4):17137. doi: 10.36141/svdld.v42i4.17137

How to Cite

1.
Monteleone G, Salotti A, Ture R, Bandini G, Hughes M, Confalonieri P, et al. The Onset of Sarcoidosis in Relation to Tattoos: Focus on the Treatment Landscape. A Critical Literature Review and Case Report. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. [cited 2026 Jun. 3];43(3):18997. Available from: https://mail.mattioli1885journals.com/index.php/sarcoidosis/article/view/18997

Issue

Section

Review

How to Cite

1.
Monteleone G, Salotti A, Ture R, Bandini G, Hughes M, Confalonieri P, et al. The Onset of Sarcoidosis in Relation to Tattoos: Focus on the Treatment Landscape. A Critical Literature Review and Case Report. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. [cited 2026 Jun. 3];43(3):18997. Available from: https://mail.mattioli1885journals.com/index.php/sarcoidosis/article/view/18997